安永料大型IPO推动第四季香港IPO市场维持增长
安永发表报告指,第三季全球IPO市场集资额创近20年同期最高,集资额增加43%至1,653亿美元,交易宗数亦为20年同期第二高,宗数达872宗,增长14%。其中,香港第三季新股集资额大幅增长60%,名列全球第三。
该行指出,有数宗大型IPO即将上市,预计香港IPO市场於2020年第四季度将维持增长势头,包括医疗科技、金融科技、供应链、物流、教育以及持续发展相关的企业都将来港上市。
安永亚太区上市服务主管合夥人蔡伟荣表示,近期上市的新经济公司以及未受疫情影响的公司都录得高估值,对寻求於第四季度完成上市的公司有正面影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.